======= ZBTB18 ======= == Gene Information == * **Official Symbol**: ZBTB18 * **Official Name**: zinc finger and BTB domain containing 18 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10472|10472]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99592|Q99592]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZBTB18&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZBTB18|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608433|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a C2H2-type zinc finger protein which acts a transcriptional repressor of genes involved in neuronal development. The encoded protein recognizes a specific sequence motif and recruits components of chromatin to target genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]. * **UniProt Summary**: Transcriptional repressor that plays a role in various developmental processes such as myogenesis and brain development. Plays a key role in myogenesis by directly repressing the expression of ID2 and ID3, 2 inhibitors of skeletal myogenesis. Also involved in controlling cell division of progenitor cells and regulating the survival of postmitotic cortical neurons. Specifically binds the consensus DNA sequence 5'- [AC]ACATCTG[GT][AC]-3' which contains the E box core, and acts by recruiting chromatin remodeling multiprotein complexes. May also play a role in the organization of chromosomes in the nucleus. {ECO:0000269|PubMed:9756912}. |BTB| |nuclear chromosome| |skeletal muscle tissue development| |skeletal muscle organ development| |transcription coactivator activity| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |sequence-specific DNA binding| |muscle structure development| |DNA-binding transcription factor activity| |cellular response to DNA damage stimulus| |negative regulation of transcription by RNA polymerase II| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular response to stress| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.85| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.72| |[[:results:exp504|MK2206 4μM R08 exp504]]|1.74| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|1.8| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.83| |[[:results:exp115|A-366 10μM R03 exp115]]|1.88| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|1.9| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.91| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.92| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|1.96| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|1.97| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.11| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.11| |[[:results:exp538|ZLN024 50μM R08 exp538]]|2.19| |[[:results:exp275|Citral 75μM R06 exp275]]|2.25| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|2.43| |[[:results:exp447|Amiloride 100μM R08 exp447]]|2.54| |[[:results:exp492|iCRT14 30μM R08 exp492]]|2.55| |[[:results:exp293|Myriocin 25μM R06 exp293]]|2.58| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|2.92| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|2.92| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|2.96| ^Gene^Correlation^ |[[:human genes:r:rbm38|RBM38]]|0.493| |[[:human genes:a:anp32a|ANP32A]]|0.46| |[[:human genes:k:kdm6a|KDM6A]]|0.423| |[[:human genes:i:itpk1|ITPK1]]|0.413| |[[:human genes:i:itpr1|ITPR1]]|0.413| |[[:human genes:m:memo1|MEMO1]]|0.401| Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10328 * **Expression level (log2 read counts)**: 6.32 {{:chemogenomics:nalm6 dist.png?nolink |}}